Santos, Renato X.Melis, ValeriaGoatman, Elizabeth A.Leith, MichaelBaddeley, Thomas C.Storey, John M.D.Riedel, GernotWischik, Claude M.Harrington, Charles R.2022-05-132022-05-132022-04-07Santos, R X, Melis, V, Goatman, E A, Leith, M, Baddeley, T C, Storey, J M D, Riedel, G, Wischik, C M & Harrington, C R 2022, 'HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine', Biomedicines, vol. 10, no. 4, 867. https://doi.org/10.3390/biomedicines10040867ORCID: /0000-0003-3737-8296/work/113225253ORCID: /0000-0002-5261-5467/work/113225819ORCID: /0000-0003-2250-3920/work/173415866https://hdl.handle.net/2164/18559Funding: This study was sponsored by WisTa Laboratories Ltd., Singapore. (grant PAR1577).212037120engAlzheimer’s diseasebioenergeticsHMTMhydromethylthioninelactatemitochondriarivastigminetau aggregation inhibitortauopathyR Medicine (General)Medicine (miscellaneous)General Biochemistry,Genetics and Molecular BiologySupplementary InformationR1HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of RivastigmineJournal article10.3390/biomedicines10040867http://www.scopus.com/inward/record.url?scp=85128469782&partnerID=8YFLogxK104